aurobindo

  1. P

    Aurobindo - misunderstanding or manipulation?

    Aurobindo’s Cronus acquisition has created huge confusion in the market - and even suspicion that the company management has overpaid massively for the acquisition, giving rise to suspicion that management might be using these methods to siphon out money from the company! During the earnings...
  2. P

    Aurobindo - punished without cause?

    Dr Reddy reported a surprise drop in Earnings, because of a court mandated payment to an earlier partner in Australia. This resulted in entire pharma sector being punished. But soon after this, Sun Pharma reported stellar results, and stock shot up to almost ₹800 levels - over a 15% jump...
  3. P

    Aurobindo’s positive aura

    6 years ago, Aurobindo acquired Natrol for $132M. https://m.economictimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-completes-132-5-million-natrol-acquisition/articleshow/45386182.cms And yesterday, they sold it for $550M. this transaction was on the books of Aurobindo...
  4. P

    COVID vaccine plays

    In the 2 weeks, Astra Zeneca shot up from 3200 to 4500, as news of its COVID vaccine progress kept market excited. In last couple of days, stock corrected sharply. I think it will raise doubts about whether there was insider info - of today’s announcement that the vaccine has issues, and will be...